S. Korea's Green Cross To Pass Dong-A In Revenues In Last Quarter
This article was originally published in PharmAsia News
Executive Summary
South Korea's Dong-A Pharmaceutical has dominated the nation's pharmaceutical industry for years, but the H1N1 flu virus could alter that landscape